Publications

• A Phase 2 PBTC Study of Selumetinib for Recurrent/Progressive Pediatric Low-Grade Glioma: Strata 2, 5, and 6 with Long-term Outcomes on Strata 1, 3, and 4.
  Neuro Oncol
  04/17/2025 Authors: Fangusaro J; Onar-Thomas A; Young Poussaint T; Lensing S; Ligon AH; Lindeman N; Banerjee A; Kilburn LB; Lenzen A; Pillay-Smiley N
• Pediatric metastatic extracranial high-grade glioma: A case report and literature review.
  Neurooncol Pract Volume: 12 Page(s): 160 - 167
  02/01/2025 Authors: Ali N; Eaton BR; Fangusaro JR; Castellino RC; Velzquez Vega JE; Chern JJ; Schniederjan M; Patil P
• Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions.
  Neuro Oncol Volume: 27 Page(s): 13 - 32
  01/12/2025 Authors: Lim-Fat MJ; Bennett J; Ostrom Q; Touat M; Franceschi E; Schulte J; Bindra RS; Fangusaro J; Dhall G; Nicholson J
• Pediatric neuro-oncology: Highlights of the last quarter-century.
  Neoplasia Volume: 59 Page(s): 101098
  01/01/2025 Authors: Power P; Straehla JP; Fangusaro J; Bandopadhayay P; Manoharan N
• Towards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation.
  Neuro Oncol Volume: 26 Page(s): 1557 - 1571
  09/05/2024 Authors: Familiar AM; Fathi Kazerooni A; Vossough A; Ware JB; Bagheri S; Khalili N; Anderson H; Haldar D; Storm PB; Resnick AC
• Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition.
  Neuro Oncol Volume: 26 Page(s): 1357 - 1366
  08/05/2024 Authors: O'Hare P; Cooney T; de Blank P; Gutmann DH; Kieran M; Milde T; Fangusaro J; Fisher M; Avula S; Packer R
• Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.
  Clin Cancer Res Volume: 30 Page(s): 2303 - 2308
  06/03/2024 Authors: Fangusaro J; Avery RA; Fisher MJ; Packer RJ; Walsh KS; Schouten-van Meeteren A; Karres D; Bradford D; Bhatnagar V; Singh H
• Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group.
  Neuro Oncol Volume: 26 Page(s): 407 - 416
  03/04/2024 Authors: Mueller S; Fangusaro J; Thomas AO; Jacques TS; Bandopadhayay P; de Blank P; Packer RJ; Fouladi M; van Meeteren AS; Jones D
• Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.
  Neuro Oncol Volume: 26 Page(s): 348 - 361
  02/02/2024 Authors: Johnson TS; MacDonald TJ; Pacholczyk R; Aguilera D; Al-Basheer A; Bajaj M; Bandopadhayay P; Berrong Z; Bouffet E; Castellino RC
• Primary Diffuse Leptomeningeal Melanomatosis in a Child with Extracranial Metastasis: Case Report.
  Curr Oncol Volume: 31 Page(s): 579 - 587
  01/20/2024 Authors: Shahab SW; Patil P; Fangusaro JR; Patteson B; Goldman-Yassen A; Eaton BR; Boydston W; Schniederjan M; Aguilera D
• Pediatric low-grade glioma: State-of-the-art and ongoing challenges.
  Neuro Oncol Volume: 26 Page(s): 25 - 37
  01/05/2024 Authors: Fangusaro J; Jones DT; Packer RJ; Gutmann DH; Milde T; Witt O; Mueller S; Fisher MJ; Hansford JR; Tabori U
• BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center's experience.
  Front Oncol Volume: 14 Page(s): 1505951
  01/01/2024 Authors: McThenia SS; Reddy KM; Damaraju E; Castellino E; He Z; Beers R; Chien F; Castellino RC; Goldman-Yassen AE; Fangusaro JR
• Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).
  Neuro Oncol Volume: 25 Page(s): 2262 - 2272
  12/08/2023 Authors: Monje M; Cooney T; Glod J; Huang J; Peer CJ; Faury D; Baxter P; Kramer K; Lenzen A; Robison NJ
• Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation.
  Neuro Oncol Volume: 25 Page(s): 1920 - 1931
  11/02/2023 Authors: Milde T; Fangusaro J; Fisher MJ; Hawkins C; Rodriguez FJ; Tabori U; Witt O; Zhu Y; Gutmann DH
• Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors.
  Pediatr Blood Cancer Volume: 70 Suppl 6 Page(s): e30600
  09/01/2023 Authors: Leary SES; Onar-Thomas A; Fangusaro J; Gottardo NG; Cohen K; Smith A; Huang A; Haas-Kogan D; Fouladi M; COG Central Nervous System Committee
• Evaluating Focal Areas of Signal Intensity (FASI) in Children with Neurofibromatosis Type-1 (NF1) Treated with Selumetinib on Pediatric Brain Tumor Consortium (PBTC)-029B.
  Cancers (Basel) Volume: 15
  03/31/2023 Authors: Pillay-Smiley N; Leach J; Lane A; Hummel T; Fangusaro J; de Blank P
• The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.
  Neoplasia Volume: 35 Page(s): 100846
  01/01/2023 Authors: Lilly JV; Rokita JL; Mason JL; Patton T; Stefankiewiz S; Higgins D; Trooskin G; Larouci CA; Arya K; Appert E
• Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
  Eur J Cancer Volume: 177 Page(s): 120 - 142
  12/01/2022 Authors: Pearson AD; Allen C; Fangusaro J; Hutter C; Witt O; Weiner S; Reaman G; Russo M; Bandopadhayay P; Ahsan S
• Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials.
  Neuro Oncol Volume: 24 Page(s): 1950 - 1961
  11/02/2022 Authors: Fonseca A; Faure-Conter C; Murray MJ; Fangusaro J; Bailey S; Goldman S; Khatua S; Frappaz D; Calaminus G; Dhall G
• MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
  Neuro Oncol Volume: 24 Page(s): 1845 - 1856
  11/02/2022 Authors: de Blank PMK; Gross AM; Akshintala S; Blakeley JO; Bollag G; Cannon A; Dombi E; Fangusaro J; Gelb BD; Hargrave D
• Nervous system (NS) Tumors in Cancer Predisposition Syndromes.
  Neurotherapeutics Volume: 19 Page(s): 1752 - 1771
  10/01/2022 Authors: Patil P; Pencheva BB; Patil VM; Fangusaro J
• Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study.
  Neuro Oncol Volume: 24 Page(s): 1404
  08/01/2022 Authors: Fangusaro JR; Onar-Thomas A; Poussaint TY; Wu S; Ligon AH; Lindeman NI; Banerjee A; Packer R; Kilburn LB; Pollack IF
• Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors.
  JCO Precis Oncol Volume: 6 Page(s): e2200107
  08/01/2022 Authors: Dankner M; Wang Y; Fazelzad R; Johnson B; Nebhan CA; Dagogo-Jack I; Myall NJ; Richtig G; Bracht JWP; Gerlinger M
• Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children's Oncology Group study.
  Neuro Oncol Volume: 24 Page(s): 974 - 983
  06/01/2022 Authors: Bartels U; Onar-Thomas A; Patel SK; Shaw D; Fangusaro J; Dhall G; Souweidane M; Bhatia A; Embry L; Trask CL
• IMAGING RESPONSE ASSESSMENT FOR CENTRAL NERVOUS SYSTEM GERM CELL TUMOURS: CONSENSUS RECOMMENDATIONS FROM THE EUROPEAN SOCIETY FOR PAEDIATRIC ONCOLOGY BRAIN TUMOUR GROUP (SIOPE-BTG) AND NORTH AMERICAN CHILDREN'S ONCOLOGY GROUP (COG)
  Volume: 24 Page(s): 53 - 54
  06/01/2022 Authors: Morana G; Shaw D; MacDonald S; Alapetite C; Ajithkumar T; Bhatia A; Brisse H; Jaimes C; Czech T; Dhall G
• ENDOSCOPIC THIRD VENTRICULOSTOMY (ETV) AND TUMOR BIOPSY ARE NOT ASSOCIATED WITH RELAPSE RATE OR PATTERNS IN PRIMARY CENTRAL NERVOUS SYSTEM (CNS) GERM CELL TUMOR (GCT)
  Volume: 24 Page(s): 58 - 58
  06/01/2022 Authors: Yan R; Lin T; MacDonald S; Carnevale J; Bhatia A; Shaw D; Murphy E; Leary S; Bartels U; Khatua S
• EVALUATING FOCAL AREAS OF SIGNAL INTENSITY (FASI) IN CHILDREN WITH NEUROFIBROMATOSIS TYPE-1 (NF1) TREATED WITH SELUMETINIB ON PBTC-029B
  Volume: 24 Page(s): 128 - 128
  06/01/2022 Authors: Smiley NP; Leach J; Lane A; Hummel T; Fangusaro J; de Blank P
• ENDOSCOPIC EVALUATION OF VENTRICULAR DISSEMINATION IN PRIMARY CENTRAL NERVOUS SYSTEM (CNS) GERM CELL TUMORS (GCTS)
  Volume: 24 Page(s): 144 - 144
  06/01/2022 Authors: Yan R; Lin T; Carnevale J; Bhatia A; Shaw D; MacDonald S; Murphy E; Leary S; Bartels U; Khatua S
• SELUMETINIB IN PEDIATRIC PATIENTS WITH NON-NEUROFIBROMATOSIS TYPE 1-ASSOCIATED, NONOPTIC PATHWAY (OPG) AND NON-PILOCYTIC RECURRENT/PROGRESSIVE LOW-GRADE GLIOMA HARBORING BRAFV600E MUTATION OR BRAF-KIAA1549 FUSION: A MULTICENTER PROSPECTIVE PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) PHASE 2 TRIAL
  Volume: 24 Page(s): 88 - 88
  06/01/2022 Authors: Fangusaro J; Onar-Thomas A; Poussaint TY; Lensing S; Wu S; Ligon AH; Lindeman N; Stewart CF; Jones DTW; Pfister SM
• Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group.
  Lancet Oncol Volume: 23 Page(s): e218 - e228
  05/01/2022 Authors: Morana G; Shaw D; MacDonald SM; Alapetite C; Ajithkumar T; Bhatia A; Brisse H; Jaimes C; Czech T; Dhall G
• A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors.
  Int J Radiat Oncol Biol Phys Volume: 113 Page(s): 143 - 151
  05/01/2022 Authors: Murphy ES; Dhall G; Fangusaro J; Bartels U; Fouladi M; Shaw D; Khatua S; Hughes CW; Panigraphy A; Ioakeim-Ioannidou M
• Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care.
  JCO Precis Oncol Volume: 6 Page(s): e2100451
  04/01/2022 Authors: Summers RJ; Castellino SM; Porter CC; MacDonald TJ; Basu GD; Szelinger S; Bhasin MK; Cash T; Carter AB; Castellino RC
• ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium.
  AJNR Am J Neuroradiol Volume: 43 Page(s): 455 - 461
  03/01/2022 Authors: Vajapeyam S; Brown D; Ziaei A; Wu S; Vezina G; Stern JS; Panigrahy A; Patay Z; Tamrazi B; Jones JY
• Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms.
  J Clin Oncol Volume: 39 Page(s): 3822 - 3828
  12/01/2021 Authors: Sabnis HS; Shulman DS; Mizukawa B; Bouvier N; Zehir A; Fangusaro J; Fabrizio VA; Whitlow C; Winchester M; Agresta L
• Long-Term Outcomes for Children with Atrt Treated with Intensive Multimodal Therapy: An Update on DFCI #02-294
  Volume: 68 Page(s): S116 - S116
  11/01/2021 Authors: Rosenberg T; Zimmerman MA; Fisher M; Fangusaro J; Cohen K; Janss A; Bowers D; Bendel A; Goldman S; Manley P
• Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study.
  Lancet Child Adolesc Health Volume: 5 Page(s): 800 - 813
  11/01/2021 Authors: Khan S; Solano-Paez P; Suwal T; Lu M; Al-Karmi S; Ho B; Mumal I; Shago M; Hoffman LM; Dodgshun A
• A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.
  Neuro Oncol Volume: 23 Page(s): 1777 - 1788
  10/01/2021 Authors: Fangusaro J; Onar-Thomas A; Poussaint TY; Wu S; Ligon AH; Lindeman N; Campagne O; Banerjee A; Gururangan S; Kilburn LB
• Clinical Pharmacokinetics and Pharmacodynamics of Selumetinib.
  Clin Pharmacokinet Volume: 60 Page(s): 283 - 303
  03/01/2021 Authors: Campagne O; Yeo KK; Fangusaro J; Stewart CF
• Neonatal Central Nervous System Tumors.
  Clin Perinatol Volume: 48 Page(s): 35 - 51
  03/01/2021 Authors: Shahab S; Fangusaro J
• Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial.
  Pediatr Blood Cancer Volume: 68 Page(s): e28756
  02/01/2021 Authors: Fangusaro J; Mitchell DA; Kocak M; Robinson GW; Baxter PA; Hwang EI; Huang J; Onar-Thomas A; Dunkel IJ; Fouladi M
• Advances in the classification and treatment of pediatric brain tumors.
  Curr Opin Pediatr Volume: 33 Page(s): 26 - 32
  02/01/2021 Authors: Fangusaro J; Bandopadhayay P
• Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors.
  Front Oncol Volume: 11 Page(s): 660892
  01/01/2021 Authors: Fangusaro J; Cefalo MG; Garr ML; Marshall LV; Massimino M; Benettaib B; Biserna N; Poon J; Quan J; Conlin E
• CLINICAL CHARACTERISTICS OF LOCALIZED CENTRAL NERVOUS SYSTEM NON-GERMINOMATOUS GERM CELL TUMORS (NGGCT) PATIENTS ENROLLED ON ACNS1123 WITH RELAPSE: A CHILDREN'S ONCOLOGY GROUP (COG) STUDY
  Volume: 22 Page(s): 336 - 336
  12/01/2020 Authors: Dhall G; Wu S; Onar-Thomas A; Shaw D; MacDonald S; Murphy E; Khatua S; Bartels U; Fangusaro J
• A PHASE 2 TRIAL OF RESPONSE-BASED RADIATION THERAPY FOR PATIENTS WITH LOCALIZED CENTRAL NERVOUS SYSTEM GERM CELL TUMORS: A CHILDREN'S ONCOLOGY GROUP (COG) STUDY. IMPACT OF RAPID CENTRAL RADIOTHERAPY REVIEW ON RADIOTHERAPY QUALITY AND PATTERN OF FAILURE FOR NON-GERMINOMATOUS GERM CELL TUMORS
  Volume: 22 Page(s): 334 - 334
  12/01/2020 Authors: Murphy ES; Dhall G; Fangusaro J; Bartels U; Fouladi M; Shaw D; Khatua S; Panigraphy A; Souweidane M; Gajjar A
• PINEOBLASTOMA IN CHILDREN SIX YEARS OF AGE OR LESS: FINAL REPORT OF THE HEAD START I, II AND III EXPERIENCE
  Volume: 22 Page(s): 449 - 450
  12/01/2020 Authors: AbdelBaki MS; Abu-Arja MH; Davidson TB; Fangusaro JR; Stanek JR; Dunkel IJ; Dhall G; Gardner SL; Finlay JL
• RESPONSE-BASED RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM LOCALIZED GERMINOMA: A CHILDREN'S ONCOLOGY GROUP (COG) PROSPECTIVE PHASE 2 CLINICAL TRIAL
  Volume: 22 Page(s): 336 - 336
  12/01/2020 Authors: Bartels U; Fangusaro J; Shaw D; Bhatia A; Omar-Thomas A; Wu S; MacDonald S; Murphy E; Souweidane M; Fouladi M
• RESPONSE ASSESSMENT IN PEDIATRIC LOW-GRADE GLIOMA: RECOMMENDATIONS FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY (RAPNO) WORKING GROUP
  Volume: 22 Page(s): 355 - 355
  12/01/2020 Authors: Fangusaro J; Witt O; Driever PH; Bag A; de Blank P; Kadom N; Kilburn L; Lober R; Robison N; Fisher M
• TITLE: DEFINING THE CLINICAL AND PROGNOSTIC LANDSCAPE OF EMBRYONAL TUMORS WITH MULTI-LAYERED ROSETTES (ETMRS), A RARE BRAIN TUMOR REGISTRY (RBTC) STUDY
  Volume: 22 Page(s): 328 - 328
  12/01/2020 Authors: Khan S; Solano-Paez P; Suwal T; Al-Karmi S; Lu M; Ho B; Fouladi M; Leary S; Levy JMM; Lassaletta A
• Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group (Vol 21, pg e305, 2020)
  LANCET ONCOLOGY Volume: 21 Page(s): E553 - E553
  12/01/2020 Authors: Fangusaro J; Witt O; Driever HP
• Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Non-Germinomatous Germ Cell Tumors: Pattern of Failure and Impact of Rapid Central Radiotherapy Review
  Volume: 67 Page(s): S50 - S50
  12/01/2020 Authors: Murphy E; Dhall G; Fangusaro J; Bartels U; Fouladi M; Shaw D; Khatua S; Panigraphy A; Souweidane M; Gajjar A
• Targeted therapies for children and young adults with cancer: Single-patient use (SPU) experience at three large pediatric cancer programs
  Volume: 80 Page(s): 69 - 70
  07/01/2020 Authors: Sabnis H; Mizukawa B; Glade-Bender J; Fangusaro J; Roberts S; Whitlow C; Winchester M; O'Brien M; Agresta L; Turpin B
• Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference.
  Neuro Oncol Volume: 22 Page(s): 773 - 784
  06/09/2020 Authors: Packer RJ; Iavarone A; Jones DTW; Blakeley JO; Bouffet E; Fisher MJ; Hwang E; Hawkins C; Kilburn L; MacDonald T
• Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
  Lancet Oncol Volume: 21 Page(s): e305 - e316
  06/01/2020 Authors: Fangusaro J; Witt O; Herniz Driever P; Bag AK; de Blank P; Kadom N; Kilburn L; Lober RM; Robison NJ; Fisher MJ
• Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience.
  Pediatr Blood Cancer Volume: 67 Page(s): e28252
  06/01/2020 Authors: Abdelbaki MS; Abu-Arja MH; Davidson TB; Fangusaro JR; Stanek JR; Dunkel IJ; Dhall G; Gardner SL; Finlay JL
• The role of tumor markers for relapse detection in central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pool analysis of cooperative group clinical trials.
  Volume: 38
  05/20/2020 Authors: Fonseca A; Faure-Conter C; Murray M; Fangusaro JR; Goldman S; Bailey S; Calaminus G; Khatua S; Frappaz D; Dhall G
• The "Risk" in Pediatric Low-Grade Glioma.
  Cancer Cell Volume: 37 Page(s): 424 - 425
  04/13/2020 Authors: Fangusaro J; Bandopadhayay P
• Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
  AJNR Am J Neuroradiol Volume: 41 Page(s): 718 - 724
  04/01/2020 Authors: Vajapeyam S; Brown D; Billups C; Patay Z; Vezina G; Shiroishi MS; Law M; Baxter P; Onar-Thomas A; Fangusaro JR
• Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.
  Acta Neuropathol Volume: 139 Page(s): 223 - 241
  02/01/2020 Authors: Li BK; Vasiljevic A; Dufour C; Yao F; Ho BLB; Lu M; Hwang EI; Gururangan S; Hansford JR; Fouladi M
• Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
  J Clin Oncol Volume: 37 Page(s): 3283 - 3290
  12/01/2019 Authors: Fangusaro J; Wu S; MacDonald S; Murphy E; Shaw D; Bartels U; Khatua S; Souweidane M; Lu H-M; Morris D
• PINEOBLASTOMA SEGREGATES INTO MOLECULAR SUBTYPES WITH DISTINCT CLINICOPATHOLOGIC FEATURES: REPORT FROM THE RARE BRAIN TUMOUR CONSORTIUM
  Volume: 21 Page(s): 192 - 192
  11/01/2019 Authors: Li B; Vasiljevic A; Dufour C; Ho B; Hwang E; Gururangan S; Hansford J; Laquerriere A; Delisle M-B; Fangusaro J
• Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients.
  Neuro Oncol Volume: 21 Page(s): 934 - 943
  07/11/2019 Authors: Gross JP; Powell S; Zelko F; Hartsell W; Goldman S; Fangusaro J; Lulla RR; Smiley NP; Chang JH-C; Gondi V
• A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor.
  Cancer Cell Volume: 36 Page(s): 51 - 67.e7
  07/08/2019 Authors: Sin-Chan P; Mumal I; Suwal T; Ho B; Fan X; Singh I; Du Y; Lu M; Patel N; Torchia J
• Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
  Lancet Oncol Volume: 20 Page(s): 1011 - 1022
  07/01/2019 Authors: Fangusaro J; Onar-Thomas A; Young Poussaint T; Wu S; Ligon AH; Lindeman N; Banerjee A; Packer RJ; Kilburn LB; Goldman S
• A phase II clinical study of pomalidomide (CC-4047) monotherapy for children and young adults with recurrent or progressive primary brain tumors.
  Volume: 37
  05/20/2019 Authors: Fangusaro JR; Locatelli F; Garre ML; Marshall LV; Massimino M; Benettaib B; Biserna N; Poon J; Quan J; Conlin E
• Management of pediatric low-grade glioma.
  Curr Opin Pediatr Volume: 31 Page(s): 21 - 27
  02/01/2019 Authors: de Blank P; Bandopadhayay P; Haas-Kogan D; Fouladi M; Fangusaro J
• Transcriptional repressor REST drives lineage stage-specific chromatin compaction at Ptch1 and increases AKT activation in a mouse model of medulloblastoma.
  Sci Signal Volume: 12
  01/22/2019 Authors: Dobson THW; Tao R-H; Swaminathan J; Maegawa S; Shaik S; Bravo-Alegria J; Sharma A; Kennis B; Yang Y; Callegari K
• PINEOBLASTOMA IN CHILDREN: THE HEAD START EXPERIENCE
  Volume: 20 Page(s): 203 - 203
  11/01/2018 Authors: AbdelBaki M; Abu Arja M; Funk Z; Stanek J; Davidson T; Fangusaro J; Dunkel I; Dhall G; Gardner S; Finlay J
• RADIATION DNA DAMAGE REPAIR INHIBITION BY GSK-J4 INDUCED CHROMATIN COMPACTION IN DIPG
  Volume: 20 Page(s): 204 - 204
  11/01/2018 Authors: Louis N; Zou L; Unruh D; Ozark PA; Piunti A; Gorbunova V; He X; Katagi H; Gryzlo D; Zhang A
• A Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT): A Children's Oncology Group (COG) Study. Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors
  Volume: 102 Page(s): S49 - S50
  11/01/2018 Authors: Murphy ES; Fangusaro J; Dhall G; Bartels U; Fouladi M; Shaw D; Khatua S; Hughes CW; Panigraphy A; Souweidane M
• Neuropsychological Outcomes of Pediatric Brain Tumor Patients Treated with Proton (PRT) or X-ray (XRT) Radiation Therapy
  Volume: 102 Page(s): S52 - S52
  11/01/2018 Authors: Gross J; Powell S; Zelko F; Hartsell WF; Goldman S; Fangusaro J; Lulla R; Smiley NP; Chang JHC; Gondi V
• Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma.
  Neuro Oncol Volume: 20 Page(s): 1547 - 1555
  10/09/2018 Authors: Gupta N; Goumnerova LC; Manley P; Chi SN; Neuberg D; Puligandla M; Fangusaro J; Goldman S; Tomita T; Alden T
• RADIATION DNA DAMAGE REPAIR INHIBITION BY GSK-J4 INDUCED CHROMATIN COMPACTION IN DIPG
  Volume: 20 Page(s): 61 - 62
  06/01/2018 Authors: Louis N; He X; Unruh D; Piunti A; Zou L; Ozark P; Tianc X; Gorbunova V; Katagi H; Gryzlo D
• PINEOBLASTOMA SEGREGATES INTO MOLECULAR SUBTYPES WITH DISTINCT CLINICOPATHOLOGIC FEATURES: REPORT FROM THE RARE BRAIN TUMOR CONSORTIUM
  Volume: 20 Page(s): 72 - 73
  06/01/2018 Authors: Li B; Vasiljevic A; Ho B; Norman J; Lu M; Hwang E; Hansford J; Jouvet A; Laquerriere A; Delisle M-B
• REPRESSIVE CHROMATIN REMODELERS IN SHH-DRIVEN MEDULLOBLASTOMA
  Volume: 20 Page(s): 141 - 141
  06/01/2018 Authors: Tao R-H; Dobson T; Maegawa S; Swaminathan J; Shaik S; Taylor P; Kennis B; Qi L; Khatua S; Goldman S
• REST MODULATES NEOVASCULATURE VIA REGULATION OF GREMLIN EXPRESSION IN DIFFUSE INTRINSIC PONTINE GLIOMA
  Volume: 20 Page(s): 62 - 62
  06/01/2018 Authors: Shaik S; Kennis B; Maegawa S; Schadler K; Yang Y; Callegari K; Lulla R; Goldman S; Nazarian J; Rajaram V
• A PHASE 2 TRIAL OF RESPONSE-BASED RADIATION THERAPY FOR PATIENTS WITH LOCALIZED CENTRAL NERVOUS SYSTEM GERM CELL TUMORS (CNS GCT): A CHILDREN'S ONCOLOGY GROUP (COG) STUDY
  Volume: 20 Page(s): 86 - 86
  06/01/2018 Authors: Fangusaro J; Wu S; MacDonald S; Murphy E; Shaw D; Bartels U; Khatua S; Boyett J; Williams-Hughes C; Souweidane M
• IMPACT OF RADIOTHERAPY MODALITY ON NEUROPSYCHOLOGICAL OUTCOMES OF PEDIATRIC BRAIN TUMOR PATIENTS
  Volume: 20 Page(s): 179 - 179
  06/01/2018 Authors: Gross J; Powell S; Zelko F; Hartsell W; Goldman S; Fangusaro J; Lulla R; Pillay-Smiley N; Chang J; Gonda V
• Genomic landscape of pineoblastoma.
  Volume: 36
  05/20/2018 Authors: Li BK; Vasiljevic A; Ho B; Jouvet A; Hwang EI; Hansford JR; Laquerriere A; Delisle M-B; Gururangan S; Fangusaro JR
• Radiation DNA damage repair inhibition by GSK-J4 in DIPG
  Volume: 128 Page(s): 77 - 78
  04/01/2018 Authors: Louis N; He X; Piunti A; Saratsis A; Lulla R; Fangusaro J; Horbinski C; Goldman S; James C; Shilatifard A
• Pediatric low-grade gliomas: next biologically driven steps.
  Neuro Oncol Volume: 20 Page(s): 160 - 173
  01/22/2018 Authors: Jones DTW; Kieran MW; Bouffet E; Alexandrescu S; Bandopadhayay P; Bornhorst M; Ellison D; Fangusaro J; Fisher MJ; Foreman N
• REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature.
  Oncotarget Volume: 9 Page(s): 5233 - 5250
  01/12/2018 Authors: Shaik S; Kennis B; Maegawa S; Schadler K; Yanwen Y; Callegari K; Lulla RR; Goldman S; Nazarian J; Rajaram V
• TARGETING IDO1 IN HUMAN PEDIATRIC BRAIN CANCER
  Volume: 19 Page(s): 120 - 120
  11/01/2017 Authors: Lauing K; Lulla R; Lenzen A; Zhai L; Hashizume R; Fangusaro JR; Wainwright D
• Erratum to: Extended diffusion weighted magnetic resonance imaging with two-compartment and anomalous diffusion models for differentiation of low-grade and high-grade brain tumors in pediatric patients.
  Neuroradiology Volume: 59 Page(s): 1181
  11/01/2017 Authors: Burrowes D; Fangusaro JR; Nelson PC; Zhang B; Wadhwani NR; Rozenfeld MN; Deng J
• RADIATION DNA DAMAGE REPAIR INHIBITION BY GSK-J4 INDUCED CHROMATIN COMPACTION IN DIPG
  Volume: 19 Page(s): 199 - 199
  11/01/2017 Authors: Louis N; He X; Piunti A; Morgan M; Unruh D; Saratsis A; Lulla R; Fangusaro JR; Horbinski C; Goldman S
• FEASIBILITY AND SAFETY OF SURGICAL BIOPSY FOR PATIENTS WITH DIPG: PRELIMINARY RESULTS FROM DIPG-BATS
  Volume: 19 Page(s): 188 - 188
  11/01/2017 Authors: Gupta N; Goumnerova L; Ayyanar K; Gump W; Bendel A; Nagib M; Bowers D; Weprin B; Bredlau A-L; Gururangan S
• Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.
  J Neurooncol Volume: 135 Page(s): 201 - 211
  10/01/2017 Authors: Marinoff AE; Ma C; Guo D; Snuderl M; Wright KD; Manley PE; Al-Sayegh H; Sinai CE; Ullrich NJ; Marcus K
• A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.
  Neuro Oncol Volume: 19 Page(s): 1135 - 1144
  08/01/2017 Authors: Banerjee A; Jakacki RI; Onar-Thomas A; Wu S; Nicolaides T; Young Poussaint T; Fangusaro J; Phillips J; Perry A; Turner D
• Extended diffusion weighted magnetic resonance imaging with two-compartment and anomalous diffusion models for differentiation of low-grade and high-grade brain tumors in pediatric patients.
  Neuroradiology Volume: 59 Page(s): 803 - 811
  08/01/2017 Authors: Burrowes D; Fangusaro JR; Nelson PC; Zhang B; Wadhwani NR; Rozenfeld MJ; Deng J
• CHARACTERIZING IDO1 AND ITS THERAPEUTIC POTENTIAL IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
  Volume: 19 Page(s): 32 - 32
  06/01/2017 Authors: Lauing KL; Lulla RR; Zhai L; Hashizume R; Fangusaro J; Wainwright DA
• AN ANALYSIS OF IMMUNOPHENOTYPE, INCLUDING PD-L1 AND PD1 EXPRESSION, IN PEDIATRIC CNS MALIGNANCIES: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY
  Volume: 19 Page(s): 29 - 29
  06/01/2017 Authors: Hwang E; Yang C; Onar-Thomas A; Fangusaro J; Gururangan S; Yearley J; Blumenschein W; McClanahan T; Annamalai L; Kocak M
• RADIATION DNA DAMAGE REPAIR INHIBITION BY GSK-J4 INDUCED CHROMATIN COMPACTION IN DIPG
  Volume: 19 Page(s): 10 - 11
  06/01/2017 Authors: Louis N; He X; Plunti A; Saratsis A; Lulla R; Fangusaro J; Horbinski C; Goldman S; James D; Shilatifard A
• Pediatric low-grade gliomas: implications of the biologic era.
  Neuro Oncol Volume: 19 Page(s): 750 - 761
  06/01/2017 Authors: Packer RJ; Pfister S; Bouffet E; Avery R; Bandopadhayay P; Bornhorst M; Bowers DC; Ellison D; Fangusaro J; Foreman N
• GENOMIC LANDSCAPE OF DIFFUSE INTRINSIC PONTINE GLIOMA: AN ANALYSIS OF THE DIPG-BATS COHORT
  Volume: 19 Page(s): 11 - 11
  06/01/2017 Authors: Bandopadhayay P; Greenwald NF; Wala J; Sharpira O; Tracy A; Filbin M; O'Rourke R; Ho P; Sinai C; Malkin H
• FEASIBILITY AND SAFETY OF SURGICAL BIOPSY FOR PATIENTS WITH DIPG: PRELIMINARY RESULTS FROM DIPG-BATS
  Volume: 19 Page(s): 56 - 56
  06/01/2017 Authors: Gupta N; Goumnerova L; Ayyanar K; Gump W; Bendel A; Nagib M; Bowers D; Weprin B; Bredlau A-L; Gururangan S
• A phase I trial of pomalidomide for children with recurrent, progressive/refractory central nervous system (CNS) tumors: A Pediatric Brain Tumor Consortium (PBTC) study.
  Volume: 35
  05/20/2017 Authors: Fangusaro JR; Mitchell DA; Kocak M; Onar-Thomas A; Sadighi ZS; Baxter PA; Hwang EI; Huang J; Dunkel IJ; Fouladi M
• A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study.
  Volume: 35
  05/20/2017 Authors: Fangusaro JR; Onar-Thomas A; Young-Poussaint T; Wu S; Ligon AH; Lindeman NI; Banerjee A; Packer R; Kilburn LB; Pollack I
• Population Pharmacokinetics of Selumetinib and Its Metabolite N-desmethyl-selumetinib in Adult Patients With Advanced Solid Tumors and Children With Low-Grade Gliomas.
  CPT Pharmacometrics Syst Pharmacol Volume: 6 Page(s): 305 - 314
  05/01/2017 Authors: Patel YT; Daryani VM; Patel P; Zhou D; Fangusaro J; Carlile DJ; Martin PD; Aarons L; Stewart CF
• Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.
  Neuro Oncol Volume: 19 Page(s): 576 - 585
  04/01/2017 Authors: Mynarek M; Pizer B; Dufour C; van Vuurden D; Garami M; Massimino M; Fangusaro J; Davidson T; Gil-da-Costa MJ; Sterba J
• Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas.
  Volume: 19 Page(s): 289 - 297
  02/01/2017 Authors: Jakacki RI; Dombi E; Steinberg SM; Goldman S; Kieran MW; Ullrich NJ; Pollack IF; Goodwin A; Manley PE; Fangusaro J
• Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.
  Cancer Cell Volume: 30 Page(s): 891 - 908
  12/12/2016 Authors: Torchia J; Golbourn B; Feng S; Ho KC; Sin-Chan P; Vasiljevic A; Norman JD; Guilhamon P; Garzia L; Agamez NR
• The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation.
  Oncogene Volume: 35 Page(s): 6153 - 6154
  11/24/2016 Authors: Das CM; Taylor P; Gireud M; Singh A; Lee D; Fuller G; Ji L; Fangusaro J; Rajaram V; Goldman S
• INHIBITION OF RADIATION-INDUCED DNA DAMAGE REPAIR MEDIATED CHROMATIN MODIFICATION BY HISTONE H3 DEMETHYLASE INHIBITOR IN PEDIATRIC BRAINSTEM GLIOMA
  Volume: 18 Page(s): 151 - 152
  11/01/2016 Authors: Ma Q; Plunti A; Saratsis A; Lulla R; Fangusaro JR; Horbinski C; Goldman S; James CD; Shilatifard A; Hashizume R
• Characterization of IDO1 and TDO2 in pediatric central nervous system tumors
  Volume: 4
  11/01/2016 Authors: Lauing K; Lulla R; Zhai L; Hashizume R; Fangusaro J; Wainwright DA
• Severe Radiation Necrosis Successfully Treated With Bevacizumab in an Infant with Low-Grade Glioma and Tumor-Associated Intractable Trigeminal Neuralgia.
  Pediatr Blood Cancer Volume: 63 Page(s): 1671 - 1673
  09/01/2016 Authors: Pillay Smiley N; Alden T; Hartsell W; Fangusaro J
• Improving vaccine efficacy against malignant glioma.
  Oncoimmunology Volume: 5 Page(s): e1196311
  08/01/2016 Authors: Ladomersky E; Genet M; Zhai L; Gritsina G; Lauing KL; Lulla RR; Fangusaro J; Lenzen A; Kumthekar P; Raizer JJ
• DISTINCT GENE FUSIONS SEGREGATE SUB-CLASSES OF CNS-PNETs
  Volume: 18 Page(s): 15 - 15
  06/01/2016 Authors: Norman J; Torchia J; De Jay N; Picard D; Rakopoulos P; Adamek D; Catchpoole D; Clifford S; Fan X; Fangusaro J
• REST ELEVATION UNRESTRAINS SHH SIGNALING IN MEDULLOBLASTOMA
  Volume: 18 Page(s): 121 - 121
  06/01/2016 Authors: Tao R-H; Dobson T; Shaik S; Taylor P; Hatcher R; Brugmann W; Busschers E; Kennis B; Khatua S; Zaky W
• MECHANISMS OF IMMUNE RESISTANCE IN PEDIATRIC POSTERIOR FOSSA TUMORS
  Volume: 18 Page(s): 170 - 170
  06/01/2016 Authors: Brugmann W; Laureano A; Torchia J; Hatcher R; Kennis B; Khatua S; Zaky W; Sbardella G; Moyes J; Goldman S
• THE CHILDREN'S ONCOLOGY GROUP (COG) CURRENT TREATMENT APPROACH FOR CHILDREN WITH NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM (CNS) NON-GERMINOMATOUS GERM CELL TUMORS (NGGCTs)
  Volume: 18 Page(s): 46 - 46
  06/01/2016 Authors: Dhall G; Wu S; Khatua S; Bartels U; Boyett J; Fangusaro J
• THE CHILDREN'S ONCOLOGY GROUP (COG) CURRENT TREATMENT APPROACH FOR CHILDREN WITH NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM (CNS) LOCALIZED GERMINOMA (ACNS1123 STRATUM 2)
  Volume: 18 Page(s): 45 - 46
  06/01/2016 Authors: Khatua S; Fangusaro J; Dhall G; Boyett J; Wu S; Bartels U
• AREAS OF NON-CONSENSUS CHALLENGING THE MANAGEMENT OF INTRACRANIAL GERM CELL TUMOURS (ICGCT)
  Volume: 18 Page(s): 42 - 42
  06/01/2016 Authors: Murray M; Kanamori M; Takami H; Bartels U; Matsutani M; Fangusaro J; Terashima K; Nishikawa R; Nicholson J
• PEDIATRIC EPENDYMOMA: MULTI-INSTITUTIONAL EXPERIENCE REVEALS POOR LONG-TERM OVERALL SURVIVAL DESPITE FAVORABLE FIVE-YEAR OUTCOMES
  Volume: 18 Page(s): 33 - 33
  06/01/2016 Authors: Marinoff A; Guo D; Ma C; Snuderl M; Wright K; Manley P; Malkin H; Ullrich N; Marcus K; Goumnerova L
• PHASE I TRIAL OF PALBOCICLIB, A CDK4/6 INHIBITOR IN CHILDREN WITH RETINOBLASTOMA PROTEIN (RB1) + RECURRENT CENTRAL NERVOUS SYSTEM (CNS) TUMORS (PBTC 042)
  Volume: 18 Page(s): 28 - 28
  06/01/2016 Authors: Gururangan S; Becher O; Leary S; Onar-Thomas A; Huang J; Phillips J; Stewart CF; Fangusaro J; Lulla R; Baxter P
• EVALUATION OF AGE-DEPENDENT TREATMENT STRATEGIES FOR CHILDREN AND YOUNG ADULTS WITH PINEOBLASTOMA: ANALYSIS OF POOLED SIOP-E AND HEAD START DATA
  Volume: 18 Page(s): 8 - 8
  06/01/2016 Authors: Mynarek M; Pizer B; Dufour C; van Vuurden D; Garami M; Massimino M; Fangusaro J; Davidson T; Gil-da-Costa MJ; Sterba J
• PHASE 1 STUDY EVALUATING THE SAFETY AND PHARMACOKINETICS OF PANITUMUMAB IN CHILDREN WITH SOLID TUMORS
  Volume: 63 Page(s): S67 - S67
  06/01/2016 Authors: Weigel B; Banerjee A; Meany H; Malempati S; Fangusaro J; Zhang Y; Ou Y; Hoang T; Meyers P
• Consensus on the management of intracranial germ-cell tumours.
  Lancet Oncol Volume: 16 Page(s): e470 - e477
  09/01/2015 Authors: Murray MJ; Bartels U; Nishikawa R; Fangusaro J; Matsutani M; Nicholson JC
• DISSECTING THE ROLE OF EPIGENETIC MODULATORS IN SHH-DRIVEN MEDULLOBLASTOMA
  Volume: 17 Page(s): 26 - 26
  06/01/2015 Authors: Dobson T; Tao R-H; Shaik S; Taylor P; Hatcher R; Busschers E; Khatua S; Goldman S; Lulla R; Rajaram V
• MicroRNA EXPRESSION PATTERNS IN TISSUE AND CEREBROSPINAL FLUID AID INMOLECULAR CLASSIFICATION OF PEDIATRIC MEDULLOBLASTOMA
  Volume: 17 Page(s): 26 - 27
  06/01/2015 Authors: Lulla R; Laskowski J; Bi Y; Goldman S; Fangusaro J; Gopalakrishnan V
• STUDY OF EPIGENETIC DEREGULATION OF A NOVEL DEUBIQUITYLASE IN MEDULLOBLASTOMA
  Volume: 17 Page(s): 8 - 8
  06/01/2015 Authors: Hatcher R; Das C; Fangusaro J; Rajaram V; Lulla R; Goldman S; Khatua S; Sbardella G; Gopalakrishnan V
• Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis.
  Lancet Oncol Volume: 16 Page(s): 569 - 582
  05/01/2015 Authors: Torchia J; Picard D; Lafay-Cousin L; Hawkins CE; Kim S-K; Letourneau L; Ra Y-S; Ho KC; Chan TSY; Sin-Chan P
• Proton therapy and helical tomotherapy result in reduced dose deposition to the pancreas in the setting of cranio-spinal irradiation for medulloblastoma: implications for reduced risk of diabetes mellitus in long-term survivors.
  Acta Oncol Volume: 54 Page(s): 563 - 566
  04/01/2015 Authors: Brower JV; Gans S; Hartsell WF; Goldman S; Fangusaro JR; Patel N; Lulla RR; Smiley NP; Chang JH-C; Gondi V
• Involvement of the neural stem cell compartment by pediatric and adult gliomas: a retrospective review of 377 cases.
  J Neurooncol Volume: 122 Page(s): 105 - 110
  03/01/2015 Authors: Marsh JC; Goldman S; Ziel E; Bregman C; Diaz A; Byrne R; Fangusaro J
• Epigenetic deregulation of a novel deubiquitylase promotes medulloblastoma genesis
  Volume: 74
  10/01/2014 Authors: Hatcher RJ; Datar V; Das CM; Fangusaro J; Goldman S; Lulla R; Rajaram V; Gopalakrishnan V
• CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity.
  Acta Neuropathol Volume: 128 Page(s): 291 - 303
  08/01/2014 Authors: Spence T; Sin-Chan P; Picard D; Barszczyk M; Hoss K; Lu M; Kim S-K; Ra Y-S; Nakamura H; Fangusaro J
• Successful treatment of metastatic HCG-secreting germ cell tumor occurring 3 years after total resection of a pineal mature teratoma.
  Eur J Pediatr Volume: 173 Page(s): 1011 - 1015
  08/01/2014 Authors: Cardellicchio S; Farina S; Buccoliero AM; Agresti B; Genitori L; de Martino M; Fangusaro J; Sardi I
• PHASE I INDIVIDUAL DOSE TITRATION TRIAL OF THE HUMAN CORTICOTROPIN-RELEASING FACTOR (HCRF), CORTICORELIN ACETATE INJECTION (XERECEPT) IN PEDIATRIC PATIENTS WITH PERITUMORAL EDEMA OF THE BRAIN
  Volume: 16
  07/01/2014 Authors: Goldman S; Fangusaro J; Lulla R; Chi S; Manley P; Robison N; Kroon H-A; Kieran M
• GENERATION OF A NOVEL GENETIC ENGINEERED MOUSE MODEL OF MEDULLOBASTOMA
  Volume: 16 Page(s): 145 - 145
  06/01/2014 Authors: Dobson T; Busschers E; Taylor H; Hatcher R; Fangusaro J; Lulla R; Goldman S; Rajaram V; Das C; Gopalakrishnan V
• LONGITUDINAL ASSESSMENT OF CIRCULATING microRNAs IDENTIFIES PROMISING BIOMARKERS IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
  Volume: 16 Page(s): 144 - 144
  06/01/2014 Authors: Lulla RR; Laskowski J; Fangusaro J; DiPatri AJ; Alden T; Tomita T; Vanin EF; Goldman S; Soares MB
• DOES NEURAL STEM CELL COMPARTMENT INVOLVEMENT ON MRI EFFECT OUTCOMES IN PEDIATRIC GLIOMAS? A RETROSPECTIVE REVIEW OF 154 CASES
  Volume: 16 Page(s): 124 - 124
  06/01/2014 Authors: Fangusaro J; Marsh J; Bregman C; Diaz A; Byrne R; Ziel E; Goldman S
• ESTABLISHING AREAS OF CONSENSUS FOR THE MANAGEMENT OF INTRACRANIAL GERM CELL TUMOURS (ICGCTS) USING A MULTI-DISCIPLINARY DELPHI METHOD
  Volume: 16 Page(s): 32 - 32
  06/01/2014 Authors: Murray M; Bartels U; Nishikawa R; Fangusaro J; Matsutani M; Nicholson J
• MicroRNA PROFILING REVEALS TWO SUBGROUPS OF DIFFUSE INTRINSIC PONTINE GLIOMA
  Volume: 16 Page(s): 56 - 56
  06/01/2014 Authors: Lulla RR; Laskowski J; Goldman S; Gopalakrishnan V; Fangusaro J
• PROGNOSTIC FACTORS IN CHILDHOOD CNS-PNET AND PINEOBLASTOMA: AN INTERNATIONAL META-ANALYSIS OF ORIGINAL CLINICAL DATA
  Volume: 16 Page(s): 91 - 91
  06/01/2014 Authors: von Hoff K; Pizer B; Dufour C; van Vuurden DG; Garami M; Massimino M; Fangusaro J; Davidson TB; Gil da Costa MJ; Sterba J
• microRNA EXPRESSION ANALYSIS REVEALS FOUR DISTINCT GROUPS OF PEDIATRIC MEDULLOBLASTOMA
  Volume: 16 Page(s): 94 - 94
  06/01/2014 Authors: Lulla RR; Laskowski J; Fangusaro J; Goldman S; Gopalakrishnan V
• SEVERE BRAINSTEM NECROSIS SUCCESSFULLY TREATED WITH BEVACIZUMAB IN AN INFANT WITH A LOW GRADE GLIOMA FOLLOWING RADIATION FOR INTRACTABLE TRIGEMINAL NEURALGIA
  Volume: 16 Page(s): 117 - 117
  06/01/2014 Authors: Smiley NP; Alden T; Hartsell W; Fangusaro J
• Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.
  Nat Genet Volume: 46 Page(s): 451 - 456
  05/01/2014 Authors: Buczkowicz P; Hoeman C; Rakopoulos P; Pajovic S; Letourneau L; Dzamba M; Morrison A; Lewis P; Bouffet E; Bartels U
• Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study.
  Neuro Oncol Volume: 16 Page(s): 310 - 317
  01/01/2014 Authors: Gururangan S; Fangusaro J; Poussaint TY; McLendon RE; Onar-Thomas A; Wu S; Packer RJ; Banerjee A; Gilbertson RJ; Fahey F
• Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).
  Cancer Volume: 119 Page(s): 4180 - 4187
  12/01/2013 Authors: Fangusaro J; Gururangan S; Poussaint TY; McLendon RE; Onar-Thomas A; Warren KE; Wu S; Packer RJ; Banerjee A; Gilbertson RJ
• C19MC AMPLIFIED TUMOURS: A NEW HISTO-GENETIC AND DIAGNOSTIC ENTITY
  Volume: 15 Page(s): 170 - 170
  11/01/2013 Authors: Spence T; Picard D; Barszczyk M; Kim S-K; Ra Y-S; Fangusaro J; Toledano H; Nakamura H; Lafay-Cousin L; Fan X
• Unclear standard of care for pediatric high grade glioma patients.
  J Neurooncol Volume: 113 Page(s): 341 - 342
  06/01/2013 Authors: Fangusaro J; Warren KE
• Diffuse intrinsic pontine gliomas (DIPG) in adolescents can have differing presentations but similar outcomes compared to those of middle childhood.
  Volume: 31
  05/20/2013 Authors: Warren KE; Jacoby E; Fangusaro JR
• Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience.
  Childs Nerv Syst Volume: 29 Page(s): 589 - 596
  04/01/2013 Authors: Aguilera D; Mazewski C; Fangusaro J; MacDonald TJ; McNall-Knapp RY; Hayes LL; Kim S; Castellino RC
• CLINICAL AND BIOLOGIC CHARACTERISTICS OF CLEAR CELL EPENDYMOMA
  Volume: 15 Page(s): 26 - 27
  04/01/2013 Authors: de Mola RML; Laskowski J; Fangusaro J; Costa FF; Vanin EF; Goldman S; Soares MB; Lulla RR
• USP37 IS A NOVEL DEUBIQUITYLASE WITH TUMOR SUPPRESSIVE FUNCTION IN MEDULLOBLASTOMA
  Volume: 15 Page(s): 19 - 19
  04/01/2013 Authors: Hatcher RJ; Das CM; Datar V; Taylor P; Singh A; Lee D; Fuller G; Ji L; Fangusaro J; Rajaram V
• EXPRESSION OF miR-203 IS ASSOCIATED WITH AGRESSIVE AN PHENOTYPE IN PEDIATRIC MEDULLOBLASTOMA
  Volume: 15 Page(s): 17 - 17
  04/01/2013 Authors: Lulla RR; Laskowski J; Gireud M; Fangusaro J; Goldman S; Gopalakrishnan V
• STUDY OF HISTONE METHYL TRANSFERASE G9a INHIBITION IN ATRT AND MEDULLOBLASTOMA
  Volume: 15 Page(s): 13 - 14
  04/01/2013 Authors: Datar V; Bochare S; Singh A; Khatau S; Fangusaro J; Goldman S; Lulla R; Rajaram V; Gopalakrishnan V
• LONGITUDINAL ASSESSMENT OF CIRCULATING microRNAs As Biomarkers In Pediatric Central Nervous System Tumors
  Volume: 15 Page(s): 13 - 13
  04/01/2013 Authors: Lulla RR; Laskowski J; Fangusaro J; DiPatri AJ; Alden T; Vanin EF; Tomita T; Goldman S; Soares MB
• LONG-TERM OUTCOMES FROM A PROSPECTIVE PHASE II STUDY OF MULTI-AGENT SYSTEMIC AND INTRATHECAL CHEMOTHERAPY WITH AGE- AND RISK-ADAPTED RADIATION THERAPY FOR CHILDREN WITH NEWLY DIAGNOSED CNS ATYPICAL TERATOID/RHABDOID TUMOR (DFCI #02-294)
  Volume: 15 Page(s): 36 - 36
  04/01/2013 Authors: Chi S; Cohen K; Fisher M; Biegel J; Bowers D; Fangusaro J; Manley P; Janss A; Zimmerman MA; Kieran M
• The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation.
  Oncogene Volume: 32 Page(s): 1691 - 1701
  03/28/2013 Authors: Das CM; Taylor P; Gireud M; Singh A; Lee D; Fuller G; Ji L; Fangusaro J; Rajaram V; Goldman S
• Bevacizumab-associated osteonecrosis of the wrist and knee in three pediatric patients with recurrent CNS tumors.
  J Clin Oncol Volume: 31 Page(s): e24 - e27
  01/10/2013 Authors: Fangusaro J; Gururangan S; Jakacki RI; Kaste SC; Goldman S; Pollack IF; Boyett JM; Kun LE
• Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
  Pediatr Blood Cancer Volume: 59 Page(s): 934 - 938
  11/01/2012 Authors: Chiu YE; Drolet BA; Blei F; Carcao M; Fangusaro J; Kelly ME; Krol A; Lofgren S; Mancini AJ; Metry DW
• Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study.
  Neuro Oncol Volume: 14 Page(s): 1404 - 1412
  11/01/2012 Authors: Gururangan S; Fangusaro J; Young Poussaint T; Onar-Thomas A; Gilbertson RJ; Vajapeyam S; Gajjar A; Goldman S; Friedman HS; Packer RJ
• THE IMPACT OF SECOND-LOOK SURGERY UPON OUTCOME FOR CHILDREN WITH MEDULLOBLASTOMA AND OTHER CENTRAL NERVOUS SYSTEM (CNS) PRIMITIVE NEURO-ECTODERMAL TUMORS (OPNET): RESULTS FROM THE "HEAD START" II AND III MULTI-CENTER PROSPECTIVE CLINICAL TRIALS, 1997-2009
  Volume: 14 Page(s): 112 - 113
  10/01/2012 Authors: Si SJ; Flores N; Haley K; Malvar J; Fangusaro J; Dhall G; Sposto R; Davidson TB; Finlay JL; Krieger M
• Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis.
  Lancet Oncol Volume: 13 Page(s): 838 - 848
  08/01/2012 Authors: Picard D; Miller S; Hawkins CE; Bouffet E; Rogers HA; Chan TSY; Kim S-K; Ra Y-S; Fangusaro J; Korshunov A
• REST is a novel prognostic factor and therapeutic target for medulloblastoma.
  Mol Cancer Ther Volume: 11 Page(s): 1713 - 1723
  08/01/2012 Authors: Taylor P; Fangusaro J; Rajaram V; Goldman S; Helenowski IB; MacDonald T; Hasselblatt M; Riedemann L; Laureano A; Cooper L
• THE IMPACT OF SECOND-LOOK SURGERY UPON OUTCOME FOR CHILDREN WITH MEDULLOBLASTOMA AND OTHER CENTRAL NERVOUS SYSTEM (CNS) PRIMITIVE NEURO-ECTODERMAL TUMORS RESULTS FROM THE "HEAD START" TRIALS
  Volume: 14 Page(s): 118 - 118
  06/01/2012 Authors: Krieger M; Si SJ; Flores N; Haley K; Malvar J; Sposto R; Fangusaro J; Dhall G; Davidson TB; Finlay J
• RESPONSE TO BEVACIZUMAB, IRINOTECAN, AND TEMOZOLAMIDE IN RECURRENT EMBRYONAL TUMORS: A MULTI-INSTITUTIONAL EXPERIENCE
  Volume: 14 Page(s): 20 - 20
  06/01/2012 Authors: Aguilera D; Mazewski C; Fangusaro J; MacDonald T; McNall R; Hayes L; Liu Y; Castellino R
• Oncocytic Ependymoma: A Case Report
  Volume: 71 Page(s): 570 - 570
  06/01/2012 Authors: Rajaram V; Bregman C; Stellpflug W; Tadanori T; Fangusaro J
• BEVACIZUMAB (BVZ)-ASSOCIATED AVASCULAR NECROSIS (AVN) OF BONE IN THREE PEDIATRIC PATIENTS WITH RECURRENT BRAIN TUMORS
  Volume: 14 Page(s): 16 - 16
  06/01/2012 Authors: Fangusaro J; Jakacki R; Kaste S; Goldman S; Pollack I; Boyett J; Kun L; Gururangan S
• PHASE I INDIVIDUAL DOSE TITRATION TRIAL OF THE HUMAN CORTICOTROPIN-RELEASING FACTOR (HCRF), CORTICORELIN ACETATE INJECTION (XERECEPT (R)) IN PEDIATRIC PATIENTS WITH PERITUMORAL EDEMA OF THE BRAIN
  Volume: 14 Page(s): 16 - 17
  06/01/2012 Authors: Goldman S; Fangusaro J; Lulla R; Reinholdt N; Newmark M; Urban M; Chi S; Manley P; Robison N; Kroon H-A
• BEVACIZUMAB (BVZ) RELATED TOXICITIES IN CHILDREN WITH RECURRENT CENTRAL NERVOUS SYSTEM (CNS) TUMORS TREATED WITH BVZ AND IRINOTECAN (CPT-11): A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC-022)
  Volume: 14 Page(s): 17 - 17
  06/01/2012 Authors: Fangusaro J; Gururangan S; Onar-Thomas A; Packer R; Goldman S; Kaste S; Friedman H; Poussaint TY; Kun L; Boyett J
• AN INTERNET-BASED SURVEY EVALUATING THE STANDARD OF CARE IN TREATING CHILDREN WITH NEWLY DIAGNOSED HIGH GRADE GLIOMA
  Volume: 14 Page(s): 56 - 57
  06/01/2012 Authors: Fangusaro J; Warren KE
• GLIOMATOSIS CEREBRI IN A NINE YEAR OLD BOY: CASE REVIEW AND REVIEW OF THE LITERATURE
  Volume: 14 Page(s): 59 - 60
  06/01/2012 Authors: Puccetti D; Salamat S; Kennedy T; Fangusaro J; Patel N; Bradley K; Casey K; Iskandar B
• META-ANALYSIS OF HEAD START (HS) I, II AND III: OUTCOME OF CHILDREN WITH NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM (CNS) PRIMITIVE NEUROECTODERMAL TUMORS (PNET)
  Volume: 14 Page(s): 103 - 103
  06/01/2012 Authors: Davidson TB; Fangusaro JR; Ji L; Sposto R; Gardner SL; Allen JC; Dunkel IJ; Dhall G; Finlay JL
• PRIMARY THALAMIC TUMORS OF ASTROCYTIC ORIGIN: A 20-YEAR EXPERIENCE AT CHILDREN'S MEMORIAL HOSPITAL
  Volume: 14 Page(s): 64 - 65
  06/01/2012 Authors: Lulla R; Echevarria M; Alden T; DiPatri A; Tomita T; Goldman S; Fangusaro J
• MARKERS OF CELL LINEAGE CORRELATE WITH SURVIVAL AND METASTATIC POTENTIAL IN CNS-PNET
  Volume: 14 Page(s): 105 - 105
  06/01/2012 Authors: Picard D; Millar S; Hawkins C; Rogers H; Kim SK; Ra YS; Fangusaro J; Toledano H; Nakamura H; Van Meter T
• A PILOT STUDY EVALUATING LONG-TERM IMPACT OF POSTERIOR FOSSA SYNDROME ON QUALITY OF LIFE IN SURVIVORS OF CHILDHOOD MEDULLOBLASTOMA
  Volume: 14 Page(s): 111 - 111
  06/01/2012 Authors: Rubens J; Lulla RR; Lai J-S; Fangusaro J
• Identification of USP37 as a novel tumor suppressive p27-specific deubiquitylase
  Volume: 72
  04/15/2012 Authors: Das CM; Taylor HP; Fangusaro J; Rajaram V; Singh A; Helenowski I; Goldman S; Gopalakrishnan V
• Pediatric high grade glioma: a review and update on tumor clinical characteristics and biology.
  Front Oncol Volume: 2 Page(s): 105
  01/01/2012 Authors: Fangusaro J
• EFFICACY OF BEVACIZUMAB 1 CPT-11 IN CHILDREN WITH RECURRENT LOW- GRADE GLIOMA (LGG) - A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY
  Volume: 13 Page(s): 95 - 95
  11/01/2011 Authors: Gururangan S; Fangusaro J; Young-Poussaint T; Lesh S; Onar A; Gilbertson R; Packer R; McLendon R; Friedman HS; Boyett J
• TARGETING REST FOR MEDULLOBLASTOMA THERAPY
  Volume: 13 Page(s): 105 - 106
  11/01/2011 Authors: Gopalakrishnan V; Taylor P; Fangusaro J; Rajaram V; Goldman S
• THE DEUBIQUITYLASE USP37 CONTROLS P27 STABILITY IN MEDULLOBLASTOMA
  Volume: 13 Page(s): 105 - 105
  11/01/2011 Authors: Gopalakrishnan V; Das C; Gireud M; Taylor P; Singh A; Lee D; Aldape K; Fuller G; Ji L; Fangusaro J
• Long-term survival in a pediatric patient with supratentorial primitive neuro-ectodermal tumor and extraneural metastasis at diagnosis.
  Pediatr Blood Cancer Volume: 57 Page(s): 341 - 344
  08/01/2011 Authors: Rubens J; Gosiengfiao Y; Tomita T; Jacobsohn DA; Fangusaro J
• Evaluating the incidence and utility of microscopic metastatic dissemination as diagnosed by lumbar cerebro-spinal fluid (CSF) samples in children with newly diagnosed intracranial ependymoma.
  J Neurooncol Volume: 103 Page(s): 693 - 698
  07/01/2011 Authors: Fangusaro J; Van Den Berghe C; Tomita T; Rajaram V; Aguilera D; Wang D; Goldman S
• Outcome of Head Start III multinational protocol for newly diagnosed central nervous system (CNS) primitive neuroectodermal tumors (pnet) of young children.
  Volume: 29
  05/20/2011 Authors: Davidson TB; Ji L; Haley K; Dhall G; Grimm JP; Gilles FH; Gardner SL; Allen JC; Bedros AA; Etzl MM
• Recurrent pure CNS germinoma with markedly elevated serum and cerebrospinal fluid human chorionic gonadotropin-beta (HCG).
  Pediatr Blood Cancer Volume: 56 Page(s): 863 - 864
  05/01/2011 Authors: Khatua S; Phillips A; Fangusaro J; Bovan S; Dhall G; Finlay JL
• Growth hormone excess in children with neurofibromatosis type 1-associated and sporadic optic pathway tumors.
  J Pediatr Volume: 158 Page(s): 433 - 436
  03/01/2011 Authors: Josefson J; Listernick R; Fangusaro JR; Charrow J; Habiby R
• Bevacizumab and irinotecan in the treatment of children with recurrent/refractory medulloblastoma.
  Pediatr Blood Cancer Volume: 56 Page(s): 491 - 494
  03/01/2011 Authors: Aguilera DG; Goldman S; Fangusaro J
• Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018.
  J Clin Oncol Volume: 29 Page(s): 324 - 329
  01/20/2011 Authors: Warren KE; Goldman S; Pollack IF; Fangusaro J; Schaiquevich P; Stewart CF; Wallace D; Blaney SM; Packer R; Macdonald T
• Hedgehog Signaling in Pediatric Brain Tumors
  Page(s): 105 - 130
  01/01/2011 Authors: Yoon JW; Fangusaro J; Iannaccone P; Walterhouse D
• LACK OF EFFICACY OF BEVACIZUMAB (BVZ) plus IRINOTECAN (CPT-11) IN CHILDREN WITH RECURRENT EPENDYMOMA (EPN) - A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY
  Volume: 12 Page(s): 82 - 82
  11/01/2010 Authors: Gururangan S; Fangusaro J; Poussaint TY; Onar A; Gilbertson R; Packer R; McClendon R; Friedman H; Boyett J
• AN INTENSIVE MULTIMODALITY APPROACH FOR PATIENTS WITH EXTRA-RENAL, EXTRACRANIAL MALIGNANT RHABDOID TUMORS
  Volume: 55 Page(s): 913 - 913
  11/01/2010 Authors: Chi S; Fisher M; Knipstein J; Fangusaro J; Zimmerman MA; Pietrantonio J; Kieran M
• HISTONE DEACETYLASE INHIBITORS PROMOTE DEGRADATION OF THE RE-1 SILENCING TRANSCRIPTION FACTOR AND NEURONAL DIFFERENTIATION IN MEDULLOBLASTOMA
  Volume: 12 Page(s): 86 - 86
  11/01/2010 Authors: Taylor P; Kang N; Das CM; Rajaram V; Aguilera DG; Goldman S; Fangusaro J; Gopalakrishnan V
• INCIDENTAL RESOLUTION OF A RADIATION-INDUCED CAVERNOUS HEMANGIOMA (RICH) OF THE BRAIN FOLLOWING THE USE OF BEVACIZUMAB IN A CHILD WITH RECURRENT MEDULLOBLASTOMA
  Volume: 12 Page(s): 82 - 82
  11/01/2010 Authors: Aguilera D; Goldman S; Tomita T; Fangusaro J
• A 17-year-old girl with a neck mass.
  Pediatr Ann Volume: 39 Page(s): 541 - 544
  09/01/2010 Authors: Listernick R; Fangusaro J; Zimmerman D; Dilley K; Cohn R; Saker M; Rowell E; Cham E
• EVALUATING THE UTILITY OF LUMBAR CEREBRO-SPINAL FLUID (CSF) SAMPLES IN CHILDREN WITH NEWLY DIAGNOSED INTRACRANIAL EPENDYMOMA: THE CHICAGO CHILDREN'S MEMORIAL HOSPITAL EXPERIENCE
  Volume: 12 Page(s): II27 - II27
  06/01/2010 Authors: Fangusaro J; Van den Berghe C; Tomita T; Rajaram V; Aguilera D; Goldman S
• Non-cerebellar primitive neuroectodermal tumors (PNET): summary of the Milan consensus and state of the art workshop on marrow ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of childhood and adolescents.
  Pediatr Blood Cancer Volume: 54 Page(s): 638 - 640
  04/01/2010 Authors: Fangusaro J; Massimino M; Rutkowski S; Gururangan S
• Incidental resolution of a radiation-induced cavernous hemangioma of the brain following the use of bevacizumab in a child with recurrent medulloblastoma.
  Pediatr Neurosurg Volume: 46 Page(s): 303 - 307
  01/01/2010 Authors: Aguilera D; Tomita T; Goldman S; Fangusaro J
• Glioblastoma multiforme in a patient with chronic granulomatous disease treated with subtotal resection, radiation, and thalidomide: case report of a long-term survivor.
  J Pediatr Hematol Oncol Volume: 31 Page(s): 965 - 969
  12/01/2009 Authors: Aguilera DG; Tomita T; Rajaram V; Fangusaro J; Katz BZ; Shulman S; Goldman S
• MANAGEMENT OF YOUNG CHILDREN NEWLY DIAGNOSED WITH CNS EMBRYONAL TUMORS: 18 YEARS OF THREE SEQUENTIAL IRRADIATION-AVOIDING CHEMOTHERAPY STUDIES-THE "HEAD START" PROTOCOLS
  Volume: 11 Page(s): 875 - 876
  12/01/2009 Authors: Finlay JL; Haley K; Dhall G; Fangusaro J; Chi S; Allen J; Sands S; Sposto R; Gardner S
• Introduction to a special issue on pediatric neuro-oncology.
  J Child Neurol Volume: 24 Page(s): 1341 - 1342
  11/01/2009 Authors: Fangusaro J; Chi S
• Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas.
  J Child Neurol Volume: 24 Page(s): 1409 - 1417
  11/01/2009 Authors: Fangusaro J
• REST EXPRESSION AND ITS PROGNOSTIC RELEVANCE IN EPENDYMOMAS
  Volume: 11 Page(s): 652 - 652
  10/01/2009 Authors: Aguilera DG; Rajaram V; Fangusaro J; Tomita T; Gopalakrishnan V; Wen S; Goldman S
• PROLONGED PROGRESSION-FREE SURVIVAL IN TWO PEDIATRIC PATIENTS WITH RECURRENT/REFRACTORY MEDULLOBLASTOMA TREATED WITH A COMBINATION OF BEVACIZUMAB AND IRINOTECAN
  Volume: 11 Page(s): 637 - 637
  10/01/2009 Authors: Fangusaro J; Goldman S; Aguilera DG
• Endocrine late effects: manifestations and treatments.
  Cancer Treat Res Volume: 150 Page(s): 155 - 182
  01/01/2009 Authors: Fangusaro JR; Littlejohn EE
• Aggressive variant of a papillary glioneuronal tumor. Report of 2 cases.
  J Neurosurg Pediatr Volume: 3 Page(s): 46 - 52
  01/01/2009 Authors: Javahery RJ; Davidson L; Fangusaro J; Finlay JL; Gonzalez-Gomez I; McComb JG
• A 17-year-old boy with fever, sore throat, and headache.
  Pediatr Ann Volume: 38 Page(s): 9 - 13
  01/01/2009 Authors: Listernick R; Katz B; Fuleihan R; Cohran V; Liem R; Morgan E; Fangusaro J; Melin-Aldana H
• PHASE I TRIAL OF CC-5013 (LENALIDOMIDE) IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY PRIMARY CNS TUMORS
  Volume: 10 Page(s): 835 - 836
  10/01/2008 Authors: Warren K; Goldman S; Stewart C; Jakacki R; Fangusaro J; Schaiquevich P; Boyett J; Kun L
• AGGRESSIVE CLINICAL BEHAVIOR OF A WELL-DIFFERENTIATED CENTRAL NERVOUS SYSTEM GLIONEURONAL TUMOR WITH UNIQUE MULTI-NUCLEATED CELLS IN A CHILD
  Volume: 10 Page(s): 833 - 833
  10/01/2008 Authors: Puccetti D; Iskandar B; Salamat S; Fangusaro J
• Phase II trial thalidomide and carboplatin for the treatment of brainstem glioma (CNS1099)
  Volume: 10 Page(s): 392 - 393
  06/01/2008 Authors: Goldman S; Tomita T; Marymont M; Hannon S; Newmark M; Weinstein J; Bendel A; Etzl M; Evans L; Fouts M
• Rare extraneural metastasis from a primary SPNET: Diagnosis and management
  Volume: 10 Page(s): 400 - 400
  06/01/2008 Authors: Fangusaro J; Gosiengfiao Y; Jacobsohn D; Tomita T
• Growth hormone excess associated with hypothalamic tumors in children
  Volume: 10 Page(s): 439 - 439
  06/01/2008 Authors: Habiby R; Josefson J; Zimmerman D; Kreiter M; Fangusaro J; Goldman S; Tomita T; Charrow J; Listernick R
• Thalamic tumors: The children's memorial hospital experience
  Volume: 10 Page(s): 475 - 475
  06/01/2008 Authors: Echevarria ME; Fangusaro J; Tomita T; Goldman S
• Pediatric central nervous system germ cell tumors: a review.
  Oncologist Volume: 13 Page(s): 690 - 699
  06/01/2008 Authors: Echevarra ME; Fangusaro J; Goldman S
• Case study of NF-1-associated optic pathway glioma: Unreported cause of vision loss
  Volume: 10 Page(s): 461 - 461
  06/01/2008 Authors: Parness-Yossifon R; Fangusaro JR; Sandu M; Listernick RH; Charrow J; Dipatri AJ; Klein-Gitelman MS; Zeid JL
• Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma.
  Pediatr Blood Cancer Volume: 50 Page(s): 699 - 700
  03/01/2008 Authors: Rook J; Rosser T; Fangusaro J; Finlay J
• Brainstem primitive neuroectodermal tumors (bstPNET): Results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue
  PEDIATRIC BLOOD & CANCER Volume: 50 Page(s): 715 - 717
  03/01/2008 Authors: Fangusaro JR; Jubran RF; Allen J; Gardner S; Dunkel IJ; Rosenblum M; Atlas MP; Gonzalez-Gomez I; Miller D; Finlay JL
• Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
  Pediatr Blood Cancer Volume: 50 Page(s): 715 - 717
  03/01/2008 Authors: Fangusaro JR; Jubran RF; Allen J; Gardner S; Dunkel IJ; Rosenblum M; Atlas MP; Gonzalez-Gomez I; Miller D; Finlay JL
• Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
  Pediatr Blood Cancer Volume: 50 Page(s): 312 - 318
  02/01/2008 Authors: Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S
• Brainstem primitive neuroectodermal tumors (bsPNET): Results of treatment with head start protocols
  Volume: 9 Page(s): 207 - 207
  04/01/2007 Authors: Fangusaro J; Jubran R; Gardner S; Gonzalez I; Miller D; Finlay JL
• Multiply recurrent CNS pure germinoma with elevated beta-HCG: Responsiveness to a systemic chemotherapy regimen of paclitaxel, gemcitabine, and oxaliplatin
  Volume: 9 Page(s): 213 - 213
  04/01/2007 Authors: Fangusaro J; Gonzalez I; Lavey R; Finlay JL
• Supratentorial primitive neuroectodermal tumors: Final outcome for children enrolled on head start I and II
  Volume: 9 Page(s): 192 - 192
  04/01/2007 Authors: Fangusaro J; Gardner S; Abromowitch M; Allen J; Atlas M; Asgharzadeh S; Chi S; Comito M; Cornelius A; Diez B
• Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis.
  Blood Volume: 109 Page(s): 1479 - 1489
  02/15/2007 Authors: Caldas H; Fangusaro JR; Bou DR; Holloway MP; Altura RA
• Pediatric brain metastasis from extraneural malignancies: a review.
  Cancer Treat Res Volume: 136 Page(s): 143 - 168
  01/01/2007 Authors: Goldman S; Echevarra ME; Fangusaro J
• Central nervous system (CNS) papillary glioneuronal tumor: Two rare cases of progressive/recurrent disease
  Volume: 8 Page(s): 467 - 467
  10/01/2006 Authors: Fangusaro J; Gonzales I; McComb G; Finlay J
• Survivin: an inhibitor of apoptosis in pediatric cancer.
  Pediatr Blood Cancer Volume: 47 Page(s): 4 - 13
  07/01/2006 Authors: Fangusaro JR; Caldas H; Jiang Y; Altura RA
• Essential role for survivin in early brain development.
  J Neurosci Volume: 25 Page(s): 6962 - 6970
  07/27/2005 Authors: Jiang Y; de Bruin A; Caldas H; Fangusaro J; Hayes J; Conway EM; Robinson ML; Altura RA
• Survivin splice variants regulate the balance between proliferation and cell death.
  Oncogene Volume: 24 Page(s): 1994 - 2007
  03/17/2005 Authors: Caldas H; Jiang Y; Holloway MP; Fangusaro J; Mahotka C; Conway EM; Altura RA
• Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome.
  Br J Cancer Volume: 92 Page(s): 359 - 365
  01/31/2005 Authors: Fangusaro JR; Jiang Y; Holloway MP; Caldas H; Singh V; Bou DR; Hayes J; Altura RA
• Survivin and Survivin isoforms in medulloblastoma show unique patterns of expression and prognostic value
  Volume: 6 Page(s): 405 - 405
  10/01/2004 Authors: Fangusaro J; Jiang YY; Singh V; Boue D; Altura R
• Topoisomerase expression in central primitive neuroectodermal tumor (cPNET)
  Volume: 84 Page(s): 275 - 275
  02/01/2004 Authors: Singh V; Fangusaro J; Altura R; Boue D
• Inflammatory myofibroblastic tumor following hematopoietic stem cell transplantation: report of two pediatric cases.
  Bone Marrow Transplant Volume: 33 Page(s): 103 - 107
  01/01/2004 Authors: Fangusaro J; Klopfenstein K; Groner J; Hammond S; Altura RA